Mechanisms that result in damage during and following cerebral ischemia

Neuroscience and Biobehavioral Reviews

Volumn 21, Issue 2, 1997, Pages 121-128

  Juurlink, Bernhard H J ^a   Sweeney, Marva I ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Acidosis; Adenosine; Apoptosis; Calcium; Free radicals; Glutamate; Hypoxia; Inflammation; Necrosis; Neuronal rescue; Nutrition; Spreading depression; Stroke

Indexed keywords

ADENOSINE; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; FREE RADICAL; GLUTAMIC ACID; MONOAMINE OXIDASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SELEGILINE; TIRILAZAD;

ACIDOSIS; ANIMAL CELL; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN PROTECTION; CALCIUM CELL LEVEL; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DIETARY INTAKE; HUMAN; INFLAMMATION; MEMBRANE POTENTIAL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; STROKE;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS;

EID: 0031041262     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(96)00001-2     Document Type: Article

References (78)

1. Ames, A. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies on retina. Can. J. Physiol. Pharmac. 70:S158-164; 1992.
2. Barone F.C., Prince W.J., Jakobsen P., Sheardown M.J., Feuerstein G. Pharmacological profile of a novel neuronal calcium channel blocker includes reduced cerebral damage and neurological deficits in rat focal ischemia. Pharmac. Biochem. Behav. 48:1994;77-85.
3. Bartus R.T., Elliott P.J., Hayward N.J., Dean R.L., Harbeson S., Straub J.A., Li Z., Powers J.C. Calpain as a novel target for treating acute neurodegenerative disorders. Neurol. Res. 17:1995;249-258.
4. Beilharz E.J., Williams C.E., Dragunow M., Sirimanne E.S., Gluckman P.D. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Molec. Brain Res. 29:1995;1-14.
5. Berezovskaya O., Maysinger D., Fedoroff S. The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS; congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury. Int. J. Dev. Neurosci. 13:1995;285-299.
6. Bickler, P.E.; Gallego, S.M. Inhibition of brain calcium channels by plasma proteins from anoxic turtles. Am. J. Physiol. 265:R277-281; 1993.
7. Chan P.H. Oxygen radicals in focal cerebral ischemia. Brain Pathol. 4:1994;59-64.
8. Chan P.H., Schmidley J.W., Fishman R.A., Longar S.M. Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurol. 34:1984;315-320.
9. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
10. Dietrich W.D., Busto R., Alonso O., Globus M.Y.T., Ginsberg M.D. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 13:1993;541-549.
11. Doll, C.J.; Hochachka, P.W.; Reiner, P.B. Channel arrest: implications from membrane resistance in turtle neurons. Am. J. Physiol. 261:R1321-1324; 1991.
12. Fandrey J. Hypoxia-inducible gene expression. Respir. Physiol. 101:1995;1-10.
13. Farooqui A.A., Horrocks L.A. Involvement of glutamate receptors, lipases, and phospholipases in long-term potentiation and neurodegeneration. J. Neurosci. Res. 38:1994;6-11.
14. Fawthrop D.J., Boobis A.R., Davies D.S. Mechanisms of cell death. Arch. Toxic. 65:1991;437-444.
15. Fisher M. Potentially effective therapies for acute ischemic stroke. Eur. Neurol. 35:1995;3-7.
16. Gerritsen M.E., Carley W.W., Ranges G.E., Shen C.P., Phan S.A., Ligon G.F., Perry C.A. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am. J. Pathol. 147:1995;278-292.
17. Ginsberg M.D., Pulsinelli W.A. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann. Neurol. 36:1994;553-554.
18. Ginsberg M.D., Sternau L.L., Globus M.Y.T., Dietrich W.D., Busto R. Therapeutic modulation of brain temperature: relevance to ischemic brain injury. Cerebrovasc. Brain Metab. Rev. 4:1992;189-225.
19. Globus M.Y.T., Alonso O., Dietrich W.D., Busto R., Ginsberg M.D. Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J. Neurochem. 65:1995;1704-1711.
20. Grace P.A. Ischaemia-reperfusion injury. Br. J. Surg. 81:1994;637-647.
21. Hakim, A.M. The cerebral ischemic penumbra. Can. J. Neurol. Sci. 557-559; 1987.
22. Hall E.D. Cerebral ischaemia, free radicals and antioxidant protection. Biochem. Soc. Trans. 21:1993;334-339.
23. Hall E.D., McCall J.M., Means E.D. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv. Pharmac. 28:1994;221-268.
24. Hill I.E., Macmanus J.P., Rasquinha I., Tuor U.I. DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 676:1995;398-403.
25. Hossmann K.-A. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36:1994;557-565.
26. Hossmann K.-A. Glutamate-mediated injury in focal cerebral ischemia - the excitotoxin hypothesis revised. Brain Pathol. 4:1994;23-36.
27. Husain J., Juurlink B.H.J. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res. 698:1995;86-94.
28. Juurlink B.H.J., Hertz L. Ischemia-induced death of astrocytes and neurons in primary culture: pitfalls in quantifying neuronal cell death. Dev. Brain Res. 71:1993;239-246.
29. Kaste M., Fogelholm R., Erilä T., Palomäki H., Murros K., Rissanen A., Sarna S. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke. 25:1994;1348-1353.
30. Kihara S., Shiraishi T., Nakagawa S., Toda K., Tabuchi K. Visualization of DNA double strand breaks in the gerbil hippocampal CA1 following transient ischemia. Neurosci. Lett. 175:1994;133-136.
31. Kirschner P.B., Henshaw R., Weise J., Trubetskoy V., Finklestein S., Schulz J.B., Beal M.F. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J. Cereb. Blood Flow Metab. 15:1995;619-623.
32. Knollema S., Aukema W., Hom H., Korf J., Terhorst G.J. L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia. Stroke. 26:1995;1883-1887.
33. Kurtzke J.F. Epidemiology of stroke: methods and trends. Statistics Canada Health Reports. 6:1994;13-19.
34. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
35. Lutz P.L. Mechanisms for anoxic survival in the vertebrate brain. Ann. Rev. Physiol. 54:1992;601-618.
36. Lutz, P.L.; Leone Kabler, S.L. Upregulation of the GABAA/benzodiazepine receptor during anoxia in the freshwater turtle brain. Am. J. Physiol. 268:R1332-1335; 1995.
37. Matsui Y., Kumagae Y. Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia. Neurosci. Lett. 126:1991;175-178.
38. Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., Satoh M. Induction of interleukin-1b mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58:1992;390-392.
39. 2+ release. Trends Pharmac. Sci. 16:1995;356-359.
40. Muir K.W., Lees K.R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26:1995;503-513.
41. Nash, O. The turtle. In: Williams, O., ed. Immortal Poems. New York: Washington Square Press; 1952:571.
42. 14C 2-deoxyglucose phosphorylation. J. Cereb. Blood Flow Metab. 6:1986;607-615.
43. Nilsson, G.E.; Lutz, P.L. Release of inhibitory neurotransmitters in response to anoxia in turtle brain. Am. J. Physiol. 261:R32-37; 1991.
44. Nilsson G.E., Lutz P.L. Role of GABA in hypoxia tolerance, metabolic depression and hibernation possible links to neurotransmitter evolution. Comp. Biochem. Physiol. 105C:1993;329-336.
45. Oh S.M., Betz A.L. Interaction between free radicals and excitatory amino acids in the formation of ischemic brain edema in rats. Stroke. 22:1991;915-921.
46. Pappius, H.M. Cerebral edema and the blood-brain barrier. In: Neuwelt, E.A., ed. Implications of the Blood-Brain Barrier and its Manipulation. Volume 1. New York: Plenum Medical Book Company; 1989:293-309.
47. Peng L., Juurlink B.H.J., Hertz L. Differences in transmitter release, morphology and ischemia-induced cell injury between cerebellar granule cell cultures developing in the presence and in the absence of a depolarizing potassium concentration. Devl. Brain Res. 63:1991;1-12.
48. Perez Pinzon, M.A.; Lutz, P.L.; Sick, T.J.; Rosenthal, M. Adenosine, a "retaliatory" metabolite, promotes anoxia tolerance in turtle brain. J. Cereb. Blood Flow Metab. 13:728-32; 1993.
49. Perez Pinzon, M.A.; Rosenthal, M.; Sick, T.J.; Lutz, P.L.; Pablo, J.; Mash, D. Downregulation of sodium channels during anoxia: a putative survival strategy of turtle brain. Am. J. Physiol. 262:R712-715; 1992.
50. Petrovits A., Nair C. Epidemiology of stroke in Canada. Statistics Canada Health Reports. 6:1994;39-42.
51. 2+ homeostatis, cell death, proliferation and differentation. Chem.-Biol. Interactions. 77:1991;1-23.
52. Rosenberg P.A., Aizenman E. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 103:1989;162-168.
53. Saija A., Scalese M., Lanza M., Marzulla D., Bonina F., Castella F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Rad. Biol. Med. 19:1995;481-486.
54. Sass J.B., Ang L.-C., Juurlink B.H.J. Aluminium pretreatment impairs the ability of astrocytes to protect neurons from glutamate mediated toxicity. Brain Res. 62:1993;207-214.
55. Saunders D.E., Howe F.A., van den Boogaart A., McLean M.A., Griffiths J.R., Brown M.M. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke. 26:1995;1007-1013.
56. Schoepp D.D., Conn P.J. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmac. 14:1993;13-20.
57. Seeburg P.H. The molecular biology of the mammalian glutamate receptor channels. Trends Pharmac. 14:1993;297-303.
58. Shiga Y., Onodera H., Kogure K., Yamasaki Y., Yashima Y., Shouzuhara H., Sendo F. Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci. Lett. 125:1991;110-112.
59. Shinosaki H. Neuron damage induced by some potent kainoids and neuroprotective action of new agonists for metabotropic glutamate receptors. Eur. Neuro. 34:(Suppl 3):1994;2-9.
60. Siesjö B.K., Zhao Q., Pahlmark K., Siesjo P., Katsura K., Folbergrova J. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann. Thorac. Surg. 59:1995;1316-1320.
61. Sochocka E., Juurlink B.H.J., Code W.E., Hertz V., Peng L., Hertz L. Cell death in primary cultures of mouse neurons and astrocytes during exposure to and recovery from hypoxia, substrate deprivation and simulated ischemia. Brain Res. 638:1994;21-28.
62. Spedding M., Lepagnol J. Pharmacology of sodium and calcium channel modulation in neurons: implications for neuroprotection. Biochem. Soc. Trans. 23:1995;633-636.
63. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
64. STIPAS Investigators. Safety study of tirilazad mesylate in patients with acute ischemia stroke (STIPAS) 25:418-423; 1994.
65. Sussman M.S., Bulkley G.B. Oxygen-derived free radicals in reperfusion injury. Meth. Enzym. 186:1990;711-723.
66. Swanson R.A., Farrell K., Simon R.P. Acidosis causes failure of astrocyte glutamate uptake during hypoxia. J. Cereb. Blood Flow Metab. 15:1995;417-424.
67. + channels as targets for neuro-protective drugs. Trends Pharmac. Sci. 16:1995;309-316.
68. Tombaugh G.C., Sapolsky R.M. Evolving concepts about the role of acidosis in ischemic neuropathology. J. Neurochem. 61:1993;793-803.
69. Tominaga T., Kure S., Narisawa K., Yoshimoto T. Endonuclease activation following focal ischemic injury in the rat brain. Brain Res. 608:1993;21-26.
70. Unlap T., Jope R.S. Inhibition of NFkB DNA binding activity by glucocorticoids in rat brain. Neurosci. Lett. 198:1995;41-44.
71. Vonlubitz D.K.J.E., Mckenzie R.J., Lin R.C.S., Devlin T.M., Skolnick P. MK-801 is neuroprotective but does not improve survival in severe forebrain ischemia. Eur. J. Pharmac. 233:1993;95-100.
72. Worrall D.M., Williams D.C. Sodium ion dependent transporters for neurotransmitters - a review of recent developments. Biochem. J. 297:1994;425-436.
73. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
74. Xue D., Huang Z.G., Barnes K., Lesiuk H.J., Smith K.E., Buchan A.M. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J. Cereb. Blood Flow Metab. 14:1994;251-261.
75. Yager J., Towfighi J., Vannucci R.C. Influence of mild hypothermia on hypoxic-ischemic brain damage in the immature rat. Pediatr. Res. 34:1993;525-529.
76. Yager J.Y., Kala G., Hertz L., Juurlink B.H.J. Correlation between content of high-energy phosphates and hypoxic-ischemic damage in immature and mature astrocytes. Devel. Brain Res. 82:1994;62-68.
77. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke. 26:1995;676-680.
78. Yang G.-Y., Betz A.L. Reperfusion-induced injury to the blood-brain-barrier after middle cerebral artery occlusion in rats. Stroke. 25:1994;1658-1665.